In response to an acute injury in the low back, the brain typically reduces the neural drive that activates the multifidus muscle, resulting in reduced multifidus activity. Because the multifidus ...
The Food and Drug Administration (FDA) has approved Sarclisa ® (isatuximab-irfc) in combination with bortezomib, lenalidomide and dexamethasone (VRd) for the treatment of patients with newly diagnosed ...